IMMUNIC, INC. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Immunic, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Immunic, Inc. Return On Equity for the quarter ending June 30, 2024 was -170 %, a 28.1% decline year-over-year.
  • Immunic, Inc. annual Return On Equity for 2023 was -157 %, a 59.6% decline from 2022.
  • Immunic, Inc. annual Return On Equity for 2022 was -98.6 %, a 40.8% decline from 2021.
  • Immunic, Inc. annual Return On Equity for 2021 was -70.1 %, a 79.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -157 -58.8 -59.6% Jan 1, 2023 Dec 31, 2023
2022 -98.6 -28.6 -40.8% Jan 1, 2022 Dec 31, 2022
2021 -70.1 -31 -79.4% Jan 1, 2021 Dec 31, 2021
2020 -39.1 +39.2 +50.1% Jan 1, 2020 Dec 31, 2020
2019 -78.3 -135 -237% Jan 1, 2019 Dec 31, 2019
2018 56.9 +158 Jan 1, 2018 Dec 31, 2018
2017 -101 -42 -71.4% Jan 1, 2017 Dec 31, 2017
2016 -58.9 +11.8 +16.7% Jan 1, 2016 Dec 31, 2016
2015 -70.7 +22 +23.8% Jan 1, 2015 Dec 31, 2015
2014 -92.7 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.